The Role of Interleukin-33 in Organ Fibrosis

Overview

Journal Discov Immunol

Specialty Allergy & Immunology

Date 2024 Apr 3

PMID 38566909

Authors

Samuele Di Carmine

Molly M Scott

Mairi H McLean

Henry J McSorley

Affiliations

Soon will be listed here.

Abstract

Interleukin (IL)-33 is highly expressed in the nucleus of cells present at barrier sites and signals via the ST2 receptor. IL-33 signalling via ST2 is essential for return to tissue homeostasis after acute inflammation, promoting fibrinogenesis and wound healing at injury sites. However, this wound-healing response becomes aberrant during chronic or sustained inflammation, leading to transforming growth factor beta (TGF-β) release, excessive extracellular matrix deposition, and fibrosis. This review addresses the role of the IL-33 pathway in fibrotic diseases of the lung, liver, gastrointestinal tract, skin, kidney and heart. In the lung and liver, IL-33 release leads to the activation of pro-fibrotic TGF-β, and in these sites, IL-33 has clear pro-fibrotic roles. In the gastrointestinal tract, skin, and kidney, the role of IL-33 is more complex, being both pro-fibrotic and tissue protective. Finally, in the heart, IL-33 serves cardioprotective functions by favouring tissue healing and preventing cardiomyocyte death. Altogether, this review indicates the presence of an unclear and delicate balance between resolving and pro-fibrotic capabilities of IL-33, which has a central role in the modulation of type 2 inflammation and fibrosis in response to tissue injury.

Citing Articles

Emerging Anti-Inflammatory COPD Treatments: Potential Cardiovascular Impacts.

Cazzola M, Calzetta L, Rogliani P, Matera M Int J Chron Obstruct Pulmon Dis. 2024; 19:2481-2495.

PMID: 39606712 PMC: 11600434. DOI: 10.2147/COPD.S498255.

The production, function, and clinical applications of IL-33 in type 2 inflammation-related respiratory diseases.

Gu S, Wang R, Zhang W, Wen C, Chen C, Liu S Front Immunol. 2024; 15:1436437.

PMID: 39301028 PMC: 11410612. DOI: 10.3389/fimmu.2024.1436437.

Hepatocyte GPCR signaling regulates IRF3 to control hepatic stellate cell transdifferentiation.

Yu J, Choi M, Lee N, Kwon A, Lee E, Koo J Cell Commun Signal. 2024; 22(1):48.

PMID: 38233853 PMC: 10795343. DOI: 10.1186/s12964-023-01416-6.

Activation of ILC2s through constitutive IFNγ signaling reduction leads to spontaneous pulmonary fibrosis.

Otaki N, Motomura Y, Terooatea T, Thomas Kelly S, Mochizuki M, Takeno N Nat Commun. 2023; 14(1):8120.

PMID: 38097562 PMC: 10721793. DOI: 10.1038/s41467-023-43336-6.

Exploring the contribution of pro-inflammatory cytokines to impaired wound healing in diabetes.

Nirenjen S, Narayanan J, Tamilanban T, Subramaniyan V, Chitra V, Fuloria N Front Immunol. 2023; 14:1216321.

PMID: 37575261 PMC: 10414543. DOI: 10.3389/fimmu.2023.1216321.

References

Valdoz J, Johnson B, Jacobs D, Franks N, Dodson E, Sanders C . The ECM: To Scaffold, or Not to Scaffold, That Is the Question. Int J Mol Sci. 2021; 22(23). PMC: 8657545. DOI: 10.3390/ijms222312690. View

Luzina I, Kopach P, Lockatell V, Kang P, Nagarsekar A, Burke A . Interleukin-33 potentiates bleomycin-induced lung injury. Am J Respir Cell Mol Biol. 2013; 49(6):999-1008. PMC: 3931117. DOI: 10.1165/rcmb.2013-0093OC. View

Kobori A, Yagi Y, Imaeda H, Ban H, Bamba S, Tsujikawa T . Interleukin-33 expression is specifically enhanced in inflamed mucosa of ulcerative colitis. J Gastroenterol. 2010; 45(10):999-1007. DOI: 10.1007/s00535-010-0245-1. View

Popper H, Uenfriend S . Hepatic fibrosis. Correlation of biochemical and morphologic investigations. Am J Med. 1970; 49:707-21. DOI: 10.1016/s0002-9343(70)80135-8. View

Dave J, Bayless K . Vimentin as an integral regulator of cell adhesion and endothelial sprouting. Microcirculation. 2014; 21(4):333-44. DOI: 10.1111/micc.12111. View

Venturelli N, Lexmond W, Ohsaki A, Nurko S, Karasuyama H, Fiebiger E . Allergic skin sensitization promotes eosinophilic esophagitis through the IL-33-basophil axis in mice. J Allergy Clin Immunol. 2016; 138(5):1367-1380.e5. DOI: 10.1016/j.jaci.2016.02.034. View

Chen W, Chang Y, Su C, Tsai T, Chen S, Hsing C . Upregulation of Interleukin-33 in obstructive renal injury. Biochem Biophys Res Commun. 2016; 473(4):1026-1032. DOI: 10.1016/j.bbrc.2016.04.010. View

Arranz A, Doxaki C, Vergadi E, Martinez De La Torre Y, Vaporidi K, Lagoudaki E . Akt1 and Akt2 protein kinases differentially contribute to macrophage polarization. Proc Natl Acad Sci U S A. 2012; 109(24):9517-22. PMC: 3386059. DOI: 10.1073/pnas.1119038109. View

Lipsky B, Toy D, Swart D, Smithgall M, Smith D . Deletion of the ST2 proximal promoter disrupts fibroblast-specific expression but does not reduce the amount of soluble ST2 in circulation. Eur J Immunol. 2012; 42(7):1863-9. DOI: 10.1002/eji.201142274. View

10.

Minutti C, Drube S, Blair N, Schwartz C, McCrae J, Mckenzie A . Epidermal Growth Factor Receptor Expression Licenses Type-2 Helper T Cells to Function in a T Cell Receptor-Independent Fashion. Immunity. 2017; 47(4):710-722.e6. PMC: 5654729. DOI: 10.1016/j.immuni.2017.09.013. View

11.

Drake L, Kita H . IL-33: biological properties, functions, and roles in airway disease. Immunol Rev. 2017; 278(1):173-184. PMC: 5492954. DOI: 10.1111/imr.12552. View

12.

Sedhom M, Pichery M, Murdoch J, Foligne B, Ortega N, Normand S . Neutralisation of the interleukin-33/ST2 pathway ameliorates experimental colitis through enhancement of mucosal healing in mice. Gut. 2012; 62(12):1714-23. PMC: 3841767. DOI: 10.1136/gutjnl-2011-301785. View

13.

Silver M, Margulis A, Wood N, Goldman S, Kasaian M, Chaudhary D . IL-33 synergizes with IgE-dependent and IgE-independent agents to promote mast cell and basophil activation. Inflamm Res. 2009; 59(3):207-18. DOI: 10.1007/s00011-009-0088-5. View

14.

Elias M, Zhao S, Le H, Wang J, Neurath M, Neufert C . IL-36 in chronic inflammation and fibrosis - bridging the gap?. J Clin Invest. 2021; 131(2). PMC: 7810483. DOI: 10.1172/JCI144336. View

15.

Chinthrajah S, Cao S, Liu C, Lyu S, Sindher S, Long A . Phase 2a randomized, placebo-controlled study of anti-IL-33 in peanut allergy. JCI Insight. 2019; 4(22). PMC: 6948865. DOI: 10.1172/jci.insight.131347. View

16.

Guan Y, Enejder A, Wang M, Fang Z, Cui L, Chen S . A human multi-lineage hepatic organoid model for liver fibrosis. Nat Commun. 2021; 12(1):6138. PMC: 8536785. DOI: 10.1038/s41467-021-26410-9. View

17.

Goh Y, Henderson N, Heredia J, Red Eagle A, Odegaard J, Lehwald N . Eosinophils secrete IL-4 to facilitate liver regeneration. Proc Natl Acad Sci U S A. 2013; 110(24):9914-9. PMC: 3683773. DOI: 10.1073/pnas.1304046110. View

18.

Yue B . Biology of the extracellular matrix: an overview. J Glaucoma. 2014; 23(8 Suppl 1):S20-3. PMC: 4185430. DOI: 10.1097/IJG.0000000000000108. View

19.

Peng Y, Chen D, Xu Z, Fang S, He B, Liu X . IL-33 receptor expression on myeloid and plasmacytoid dendritic cells after allergen challenge in patients with allergic rhinitis. Int Immunopharmacol. 2021; 101(Pt B):108233. DOI: 10.1016/j.intimp.2021.108233. View

20.

Baumgartner K, Samet J, Stidley C, Colby T, Waldron J . Cigarette smoking: a risk factor for idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 1997; 155(1):242-8. DOI: 10.1164/ajrccm.155.1.9001319. View